The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the Testis-Reference-Cited by-同舟云学术

The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the Testis

Published:2020-03 Issue:3 Volume:77 Page:344-351
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Cullen Michael,Huddart Robert,Joffe Johnathan,Gardiner Deborah,Maynard Lauren,Hutton Paul,Mazhar Danish,Shamash Jonathan,Wheater Matthew,White Jeff^ORCID,Goubar Aicha,Porta Nuria,Witts Stephanie,Lewis Rebecca,Hall Emma^ORCID

Funder

Cancer Research UK

Queen Elizabeth Hospital Birmingham Charity

NHS

Publisher

Elsevier BV

Subject

Urology

Reference31 articles.

1. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone;Freedman;Lancet,1987

2. Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party;Read;J Clin Oncol,1992

3. Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review;Vergouwe;J Clin Oncol,2003